Heart infection registry aims to unlock better treatments

NCT ID NCT06434012

Recruiting now Knowledge-focused Sponsor: Queen Mary University of London Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This registry collects detailed information from 1,000 patients with infective endocarditis, a serious heart infection. Researchers will track demographics, microbiology, imaging, and outcomes to understand current treatment effectiveness and guide future studies. The goal is to improve diagnosis and management of this life-threatening condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could help identify better ways to diagnose and treat infective endocarditis, potentially reducing deaths and complications.
What could go wrong: This is an observational registry, not a treatment trial. It collects data but does not test any new therapy, so direct patient benefits may take years to emerge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOCARDITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial endocarditis endocarditis infective endocarditis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOCARDITIS ENDOCARDITIS, BACTERIAL INFECTIVE ENDOCARDITIS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

St Bartholomews Hospital
RECRUITING

London, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.